Indutrade today signed an agreement to acquire all of the shares in Medexa Diagnostisk Service AB, with annual sales of approximately SEK 25 million. Medexa specialises in high-end technology for healthcare with a focus on foetal surveillance and ultrasound applications. Customers consist primarily of county councils and private clinics. Indutrade takes possession of the company today, and it will be part of the Industrial Components business area. The acquisition is expected to have a marginally positive impact on Indutrade’s earnings per share. Since 2008, annual sales in Indutrade’s medical technology segment have grown from approximately SEK 60 million to approximately SEK 400 million. Stockholm, 8 October 2013 INDUTRADE AB (publ) For further information, please contact: Johnny Alvarsson, President and CEO: +46 70 589 17 95 About Indutrade Indutrade markets and sells components, systems and services with a high-tech content within selected niches. Indutrade's business is distinguished by - high-tech products for recurring needs - growth through a structured and tried-and tested acquisition strategy - a decentralised organisation characterised by an entrepreneurial spirit. The Group is organised into five business areas: Engineering & Equipment, Flow Technology, Fluids & Mechanical Solutions, Industrial Components and Special Products. Indutrade's sales totalled SEK 8,384 million in 2012, generating operating income of SEK 905 million before depreciation of intangible assets. Indutrade is listed on the Nasdaq OMX Stockholm.
Indutrade acquires additional medtech company Indutrade
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sarepta Therapeutics Faces Legal Scrutiny Amid Regulatory Challenges
Legal Challenges for Sarepta Therapeutics The situation regarding Sarepta Therapeutics is becoming increasingly complex. Recently, a pending securities class action was initiated due to unsettling news about safety concerns linked to their medication, ELEVIDYS. This product aims to treat Duchenne muscular dystrophy, a severe condition affecting young boys. As the company...
Continue Reading
Enhancing Landscape Operations: LandCare's Partnership with Lytx+™
LandCare Enhances Operational Efficiencies with Lytx+ LandCare, a leading commercial landscaping company in the nation, has made significant strides in its operations by adopting the innovative Lytx+™ solution in conjunction with Geotab. This collaboration aims to optimize fleet safety and management, ensuring that LandCare continues to thrive in a competitive...
Continue Reading
Grand Sierra Resort Launches Ambitious $1 Billion Arena Project
Grand Sierra Resort Unveils Major Arena Development Grand Sierra Resort (GSR) has officially broken ground on a groundbreaking new arena, marking the first phase of an extensive $1 billion redevelopment project that is set to forever change the landscape of Reno. This ambitious undertaking is the largest private investment in the history of the region, signaling a bright...
Continue Reading
Saba Capital Management Adjusts Holdings in Eaton Vance Trust
Saba Capital Management Modifies Its Holdings in Eaton Vance Trust Saba Capital Management, L.P., a significant player in the investment management sector, has recently garnered attention by adjusting its position in the Eaton Vance California Municipal Income Trust (NYSE: CEV). This strategic decision involved the sale of 44,367 shares, accumulating over $484,725 over...
Continue Reading
Key Insights on Treatt Plc's Market Dealing Activities
Understanding the Amendment for Treatt Plc The recent amendment related to Treatt Plc has sparked interest in financial circles, especially among shareholders and market analysts. This document outlines public dealing disclosures from an exempt principal trader acting on behalf of a clientele, primarily concerning Treatt Plc, a prominent player in the flavor and fragrance...
Continue Reading